Evidence map›Paper›PMID 11435466›Full record

ArticleThe Journal of clinical investigation2001

Involvement of FAN in TNF-induced apoptosis.

B Ségui, O Cuvillier, S Adam-Klages, V Garcia, S Malagarie-Cazenave, S Lévêque, S Caspar-Bauguil, J Coudert, R Salvayre, M Krönke and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Alaska's Flora as a Treatment for Cancer.International journal of biopharmaceutical sciences · 2024
    Article
  3. Article
  4. System level modeling and analysis of TNF-Frontiers in physiology · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Apoptosis and necrosis in the liver.Comprehensive Physiology · 2013
    Review
  16. Article
  17. Article
  18. Article
  19. Sphingolipids in multiple sclerosis.Neuromolecular medicine · 2010
    Review
  20. Redox control of liver function in health and disease.Antioxidants & redox signaling · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

B SéguiInstitut National de la Santé et de la Recherche Médicale U466, Centre Hospitalier Universitaire Rangueil, Toulouse, France.
O Cuvillier
S Adam-Klages
V Garcia
S Malagarie-Cazenave
S Lévêque
S Caspar-Bauguil
J Coudert
R Salvayre
M Krönke
T Levade
Centre Hospitalier Universitaire de Toulouse · FRInserm · FRKiel University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TNF-alpha is a pleiotropic cytokine activating several signaling pathways initiated at distinct intracellular domains of the TNF receptors. Although the C-terminal region is believed to be responsible for apoptosis induction, the functions of more membrane-proximal domains, including the domain that couples to neutral sphingomyelinase activation, are not yet fully elucidated. The roles of this region and of the associated adapter protein FAN (factor associated with neutral SMase activation) in the cytotoxic response to TNF have been investigated. We have now shown that stable expression in human fibroblasts of a dominant negative form of FAN abrogates TNF-induced ceramide generation from sphingomyelin hydrolysis and reduces caspase processing, thus markedly inhibiting TNF-triggered apoptosis. However, the cytotoxic responses to daunorubicin and exogenous ceramide remain unaltered, as do the TNF-induced p42/p44 MAPK activation and CD54 expression. Fibroblasts from FAN-knockout mice also proved to be resistant to TNF toxicity. These findings highlight the previously unrecognized role of the adapter protein FAN in signaling cell death induction by TNF.

Indexed as

Amino Acid Chloromethyl KetonesAnimalsAntigens, CDApoptosisCaspasesCell Line, TransformedCells, CulturedCeramidesCysteine Proteinase InhibitorsDaunorubicinEnzyme ActivationFibroblastsGenes, DominantHumansHydrolysisIntercellular Adhesion Molecule-1Amino Acid Chloromethyl KetonesAntigens, CDbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneCaspasesCeramidesCysteine Proteinase InhibitorsDaunorubicinIntercellular Adhesion Molecule-1Intracellular Signaling Peptides and ProteinsMitogen-Activated Protein Kinase 1NSMAF protein, humanNsmaf protein, mouseProteinsReceptors, Tumor Necrosis FactorReceptors, Tumor Necrosis Factor, Type IRecombinant Fusion ProteinsSphingomyelin PhosphodiesteraseSphingomyelinsTumor Necrosis Factor-alpha

Identifiers

PMID11435466
PMCPMC209337
OpenAlexW2110671766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.